Navigation Links
Texcel Medical Appoints Barry Smith as President, CEO
Date:2/23/2009

EAST LONGMEADOW, Mass., Feb. 23 /PRNewswire/ -- Texcel Medical, LLC, a full service medical device process development and contract manufacturing company, has announced the appointment of Barry Smith as President and CEO.

Smith will oversee all functions at Texcel Medical, which helps companies around the world by providing the manufacturing infrastructure and expertise they need to accelerate the commercialization of their surgical, interventional, and implantable medical device technologies. The firm is headquartered in East Longmeadow, Mass.

Texcel Medical Founder and Chairman Laurence Derose, emphasized the significance of Smith's appointment. "Barry's executive experience in the medical products market is an ideal compliment to Texcel's strategic growth initiatives as we move to the next level as a long term partner," Derose said.

Prior to joining Texcel, Smith served as Chief Operating Officer and Vice President of Operations and Product Development for several medical device product and engineering companies.

Derose continues in his role as Chairman and will expand his focus on identifying and securing strategic partnerships for the organization.

Texcel Medical's medical device process development and manufacturing solutions and services includes design for manufacturability (DFM), design history file management, inventory management, quality and regulatory assistance, and process validation, along with general manufacturing, electronic testing, laser welding, and clean-room processing for a wide range of product applications. Texcel Medical has more than 20 years of experience assisting companies execute increasingly sophisticated designs through reliable manufacturing, with particular expertise in Orthopedics, Cardiac Assist, Active Implantables, Combination Products, and General Instrumentation.

For more information, visit Texcel Medical's website at www.texcelmedical.com or contact Keith Checca at Texcel Medical, 55 Deer Park Drive, East Longmeadow, MA 01028, or by phone at (413) 525-5700.

About Texcel Medical:

Texcel Medical, LLC (www.texcelmedical.com), a full service medical device process development and contract manufacturing company, creates long term partnerships with medical device companies in the areas of Class II medical electronics, Class III implantable electronics, IPG's (Implantable Pulse Generators - Neuromodulation) and laser technology and manufacturing services. Texcel Medical has served the medical device community for over 20 years and is ISO-13485 (2003) certified.


'/>"/>
SOURCE Texcel Medical, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Texcel Highlights Medical Device Development & Manufacturing Solutions at MD&M West, booth 314
2. The Medical Affairs Company Expands Its Medical Communications Division
3. IlluminOss Medical Receives ISO 13485 Certification
4. Environmental Tectonics Corporations BioMedical Divisions Hyperbaric Chambers Address U.S. President Obamas Initiative to Computerize Medical Records
5. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Monoplace Hyperbaric Chambers
6. TechniKroms Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical
7. SPO Medical Appoints New US Sales Rep Groups
8. Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon
9. Hong Kong Biotech Company, Filligent, Announces CE Certification of Its Revolutionary, Anti-Infective Medical Face Mask, the BioMask
10. American Institute for Medical and Biological Engineering Appoints Dr. Gualberto Ruano to College of Fellows
11. Cordex Pharma Forms Heart Failure Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... a United States multicenter, prospective clinical study that demonstrates the accuracy of ... capable of identifying clinically significant acute bacterial and viral respiratory tract infections ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology:
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
Breaking Biology News(10 mins):